BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03783442-completion@plaintrial.com
DTSTAMP:20261027T131825Z
DTSTART;VALUE=DATE:20240822
SUMMARY:A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy
  as First Line Treatment in Participants With Advanced Esophageal Squamous
  Cell Carcinoma — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03783442
URL:https://plaintrial.com/trial/NCT03783442
END:VEVENT
END:VCALENDAR